Cryoelectron Microscopy of Protein IX-Modified Adenoviruses Suggests a New Position for the C Terminus of Protein IX

ABSTRACT Recombinant human adenovirus is a useful gene delivery vector for clinical gene therapy. Minor capsid protein IX of adenovirus has been of recent interest since multiple studies have shown that modifications can be made to its C terminus to alter viral tropism or add molecular tags and/or reporter proteins. We examined the structure of an engineered adenovirus displaying the enhanced green fluorescent protein (EGFP) fused to the C terminus of protein IX. Cryoelectron microscopy and reconstruction localized the C-terminal EGFP fusion between the H2 hexon and the H4 hexon, positioned between adjacent facets, directly above the density previously assigned as protein IIIa. The original assignment of IIIa was based largely on indirect evidence, and the data presented herein support the reassignment of the IIIa density as protein IX.

[1]  W. Newcomb,et al.  Use of Ar+ plasma etching to localize structural proteins in viruses: studies with adenovirus 2. , 1988, Analytical biochemistry.

[2]  U. Pettersson,et al.  Structural proteins of adenoviruses. X. Isolation and topography of low molecular weight antigens from the virion of adenovirus type 2. , 1973, Virology.

[3]  M. Barry,et al.  Rapid Construction of Capsid-Modified Adenoviral Vectors Through Bacteriophage λ Red Recombination , 2004 .

[4]  W Chiu,et al.  Semi-automated icosahedral particle reconstruction at sub-nanometer resolution. , 2001, Journal of structural biology.

[5]  S. Cusack,et al.  A quasi‐atomic model of human adenovirus type 5 capsid , 2005, The EMBO journal.

[6]  Jort Vellinga,et al.  Spacers Increase the Accessibility of Peptide Ligands Linked to the Carboxyl Terminus of Adenovirus Minor Capsid Protein IX , 2004, Journal of Virology.

[7]  M. Barry,et al.  Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  T. Shenk,et al.  Adenovirus type 5 virions can be assembled in vivo in the absence of detectable polypeptide IX , 1981, Journal of virology.

[9]  Richard Hughey,et al.  Hidden Markov models for detecting remote protein homologies , 1998, Bioinform..

[10]  R. K. Evans,et al.  Development of stable liquid formulations for adenovirus-based vaccines. , 2004, Journal of pharmaceutical sciences.

[11]  Roger M. Burnett,et al.  Image reconstruction reveals the complex molecular organization of adenovirus , 1991, Cell.

[12]  F. Graham,et al.  Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. , 1987, The EMBO journal.

[13]  D. Curiel,et al.  Dynamic monitoring of oncolytic adenovirus in vivo by genetic capsid labeling. , 2006, Journal of the National Cancer Institute.

[14]  R. M. Burnett,et al.  Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  Jort Vellinga,et al.  The Coiled-Coil Domain of the Adenovirus Type 5 Protein IX Is Dispensable for Capsid Incorporation and Thermostability , 2005, Journal of Virology.

[16]  R. M. Burnett,et al.  Molecular composition of the adenovirus type 2 virion , 1985, Journal of virology.

[17]  J. Mathis,et al.  Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion. , 2005, Virology.

[18]  R. Parks,et al.  Use of adenovirus protein IX (pIX) to display large polypeptides on the virion--generation of fluorescent virus through the incorporation of pIX-GFP. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  Jort Vellinga,et al.  The adenovirus capsid: major progress in minor proteins. , 2005, The Journal of general virology.

[20]  M. Croyle,et al.  Development of formulations that enhance physical stability of viral vectors for gene therapy , 2001, Gene Therapy.

[21]  R. M. Burnett,et al.  Adenovirus polypeptide IX revealed as capsid cement by difference images from electron microscopy and crystallography. , 1989, The EMBO journal.

[22]  D. Curiel,et al.  Engineering of Adenovirus Vectors Containing Heterologous Peptide Sequences in the C Terminus of Capsid Protein IX , 2002, Journal of Virology.

[23]  M. Barry,et al.  Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting. , 2006, Virology.

[24]  P. Boulanger,et al.  Characterization of adenovirus protein IX. , 1979, The Journal of general virology.

[25]  P. Stewart,et al.  CryoEM structure at 9A resolution of an adenovirus vector targeted to hematopoietic cells. , 2005, Journal of molecular biology.

[26]  V. Sandig,et al.  Genome Size and Structure Determine Efficiency of Postinternalization Steps and Gene Transfer of Capsid-Modified Adenovirus Vectors in a Cell-Type-Specific Manner , 2004, Journal of Virology.

[27]  R. Parks Adenovirus protein IX: a new look at an old protein. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  B. Berger,et al.  MultiCoil: A program for predicting two‐and three‐stranded coiled coils , 1997, Protein science : a publication of the Protein Society.

[29]  K. Leppard,et al.  Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5 , 1995, Journal of virology.

[30]  Roberto Marabini,et al.  Classification of single-projection reconstructions for cryo-electron microscopy data of icosahedral viruses. , 2005, Journal of structural biology.

[31]  A. Lupas,et al.  Predicting coiled coils from protein sequences , 1991, Science.

[32]  C. Kedinger,et al.  Functional Analysis of Adenovirus Protein IX Identifies Domains Involved in Capsid Stability, Transcriptional Activity, and Nuclear Reorganization , 2001, Journal of Virology.

[33]  D. Curiel,et al.  Fluorescently labeled adenovirus with pIX-EGFP for vector detection. , 2004, Molecular imaging.

[34]  P. Stewart,et al.  Difference imaging of adenovirus: bridging the resolution gap between X‐ray crystallography and electron microscopy. , 1993, The EMBO journal.

[35]  P. Ng,et al.  Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors , 2004, Gene Therapy.